A new oral polymeric controlled release formulation suitable for the once-a-day administration of valproate compounds, such as divalproex sodium, has been discovered. This formulation exhibits significant advantages over the sustained release valproate formulations of the prior art. This formulation...http://www.google.ca/patents/US6528090?utm_source=gb-gplus-sharePatent US6528090 - Controlled release formulation of divalproex sodium
